DataMEDS AI, Inc. (MEDS) — Stock Valuation & Research

DataMEDS AI is a Health IT company focused on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units. The company incorporates its artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contacts platform PharmacyChain™ to optimize the prescription medicines reimbursement and dispensing journey.

MEDS key statistics

Price$1.70
Market cap$7.64M
SectorHealthcare
IndustryMedical - Distribution
ExchangeNASDAQ
52-week range0.8225-35.68
Beta-1.52

Explore MEDS's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.